We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astek | LSE:AKG | London | Ordinary Share | GB00B1B9C846 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.65 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMAKG RNS Number : 4987W Astek Group PLC 29 July 2009 Astek Group plc / Epic: AKG / Index: AIM / Sector: Medical Supplies 29 July 2009 Astek Group plc ('Astek') In accordance with AIM Rule 17, Astek is required to issue notification that York Pharma Plc, a company of which Mr Norman Freedman was a non executive director, was placed into administration on 27 July 2009. The Board of Astek are pleased to confirm that Mr Freedman will continue to act as a non executive director of Astek and that this announcement has been made to satisfy the requirements of the AIM rules for companies. For further information please contact: Alan Segal Astek Group Plc 0161 942 3900 Alex Clarkson/Tom Rowley Zeus Capital 0161 831 1512 This information is provided by RNS The company news service from the London Stock Exchange END RDNEADXNAFSNEFE
1 Year Astek Chart |
1 Month Astek Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions